The First Global Summit on Diagnostic Precision for Prostate Cancer is taking place in Boston on Sept. 16-18, 2016.
The Summit will educate key health care stakeholders about the state-of-the-art and emerging advances in prostate diagnostics and their groundbreaking impact on precision care, including personalized approaches to screening, early detection, risk assessment and treatment.
For the first time, this Summit brings together the world authorities who have been leading research and development of prostate diagnostics (biomarkers, imaging, genetics, genomics, etc.) in order to bridge the existing inter-disciplinary gaps, develop a consensus-based vision for the future of precision care and strategy for its realization.
Organized by Boston-based non-profit, AdMeTech Foundation, this event will also review promising in vitro cancer targets and their interface with in vivo imaging.
Registration and call for abstracts are now open. Visit admetech.org/summit for more information about the program, poster session, sponsorship, and hotel accommodations.
